Skip to main content
Premium Trial:

Request an Annual Quote

Syrrx Opens New San Diego Drug Discovery Center, Hires Two Chemists

NEW YORK, Aug. 7-Syrrx has opened an 84,000-square-foot structural biology, combinatorial chemistry and nanotechnology center in San Diego, the company said today.

 

The new center, which can house about 250 researchers, centralizes Syrrx's drug discovery programs and provides room for the company to expand.

 

Former GlaxoSmithKline chemical oncology director Jeffrey Stafford will manage the discovery chemistry and medicinal chemistry programs at the new research center.

 

DuPont and CombiChem veteran Daniel Kassel will be senior director of analytical technologies, overseeing company development of drug discovery technology.

The Scan

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.

Effectiveness May Decline, Data From Israel Suggests

The New York Times reports that new Israeli data suggests a decline in Pfizer-BioNTech SARS-CoV-2 vaccine effectiveness against Delta variant infection, though protection against severe disease remains high.

To See Future Risk

Slate looks into the use of polygenic risk scores in embryo screening.

PLOS Papers on Methicillin-Resistant Staphylococcus, Bone Marrow Smear Sequencing, More

In PLOS this week: genomic analysis of methicillin-resistant Staphylococcus pseudintermedius, archived bone marrow sequencing, and more.